PubMed HealthSearch

PubMed · 978567

Increment sensitivity in humans with abnormal visual experience.

Abstract

1. Visual acuity is lower for gratings oriented diagonally than for those of horizontal and vertical orientations. In addition to this oblique effect, some subjects show substantial deficits in acuity for horizontal or vertical targets (meridional amblyopia). These subjects are invariably astigmatic, but the condition has a neuronal basis and is thought to arise from faulty post-natal neural development. 2. Foveal increment sensitivites have been determined for normal subjects and meridional amblyopes using bar-shaped targets of various lengths, widths and orientations.3. Normal subjects do not exhibit differences in sensitivity as a function of orientation. No oblique effect is found for 1-5' wide bars ranging in length from 10 to 60'. On the other hand, meridional amblyopes have substantial differences in increment sensitivity which depend on test target orientation. Invariably, when there is a deficit in acuity for a particular grating orientation, there is also a reduction in increment sensitivity for a bar of the same orientation. This effect is diminshed or eliminated when the background illuminance is lowered from 70 to 7td. 4. The orientational differences in increment sensitivity found in meridional amblyopes do not increases for bars longer than about 10'. As the bar is shortened, the differences are reduced, and they are absent when the test bar is 6' or less. 5. In normal subjects, for a 1 degree long bar, increment sensitivity increases with width up to about 4' where the width-sensitivity curve levels off. No orientation differences are exhibited. Prominent orientation differences are found with meridional amblyopes when the bar target width is altered. The normal meridian is similar to those of the control subjects but the deficity meridian has very low sensitivity and summation is present for widths up to about 11'.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B L Beyerstein, R D Freeman. 1976. Increment sensitivity in humans with abnormal visual experience.. https://doi.org/10.1113/jphysiol.1976.sp011528

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Genome-Wide and Rare Variant Association Studies of Amblyopia in Admixed American and African Ancestry Groups.

OBJECTIVE: To identify genetic variants associated with amblyopia in African (AFR) and Admixed American (AMR) ancestry groups, expanding on previous studies conducted in European ancestry. DESIGN: Retrospective ancestry-stratified genome-wide association study (GWAS) and gene-level rare variant association study (RVAS). PARTICIPANTS: Participants in the All of Us Research Program from AFR and AMR ancestry groups who had whole-genome sequencing available. Cases and controls were distinguished based on the presence of International Classification of Diseases 9/10/SNOMED diagnosis codes for amblyopia in electronic health records. This yielded ancestry-stratified subsets of 269 cases and 71 585 controls of AMR ancestry and 366 cases and 79 460 controls of AFR ancestry. METHODS: Stratified logistic regression models were adjusted for age, biological sex, and the top 10 principal components of genomic ancestry. GWAS was limited to common variants (minor allele frequency &#x2265;1%), and RVAS was limited to rare variants with coding sequence-altering effects (minor allele frequency >1%, exonic only, excluding synonymous variants) aggregated at the gene level using the SKAT algorithm. Downstream analyses of the significant variants were performed using KEGG and GO pathway analysis and STRING database queries for protein-protein interactions and gene-gene interactions. MAIN OUTCOME MEASURES: Single-nucleotide polymorphisms were determined to have genome-wide significance if P < 5e-8 in the GWAS, and genes were determined to have significant association with amblyopia in the RVAS if P < 8.0 &#xd7; 10-4. RESULTS: In the AMR GWAS, 245 unique single-nucleotide polymorphisms mapping to 97 distinct loci were identified, notably within neurodevelopmental and axonal guidance genes, including ROBO1, SEMA4B, PTPRD, NRXN1, and CAMK2D. The AFR GWAS identified 11 significant variants corresponding to 6 loci mapping primarily to long noncoding RNAs and pseudogenes. The AMR RVAS identified 15 genes, including axonal transport genes (KIF1B and KIF7) and growth factor signaling genes (EGF, ERBIN, and AKAP17A). The AFR RVAS identified a single gene, DLG2, which encodes the postsynaptic protein PSD-93, which promotes the closure of the sensitive period of neuroplasticity for vision in early childhood. CONCLUSIONS: Genetic risk architectures for amblyopia differ across ancestries but fundamentally converge on neurodevelopmental signaling, cortical synapse assembly, and sensitive period plasticity rather than ocular structural dynamics. FINANCIAL DISCLOSURE(S): The authors have no proprietary or commercial interest in any materials discussed in this article.

Amblyopia

The Tokyo Metropolitan Home Vision Screening Program for amblyopia in 3-year-old children.

In August 1989, the Tokyo Metropolitan Government officially began a vision screening program for children aged 3 years 1 month. A 1988 pilot study of 1,303 children this age disclosed five cases (0.38%) of amblyopia. The home vision test, which uses picture cards of familiar figures, proved to be an efficient and inexpensive method of screening when incorporated into the existing health-check program for 3-year-old children. In the initial eight months of the program, 21,906 children were screened. Of these, 419 children (1.9%) were referred to an ophthalmologist for follow-up, and amblyopia was detected in 41 children (0.19%).

Amblyopia